The Threat of Emerging Infectious Diseases in Asia
Transcription
The Threat of Emerging Infectious Diseases in Asia
The Threat of Emerging Infectious Diseases in Asia Linfa Wang/Professor and Director EID Program, Duke-NUS Graduate Medical School, Singapore CSIRO Australian Animal Health Laboratory, Geelong, Australia [email protected] The SARS outbreak “Seven people stood waiting for an elevator in a hotel lobby (Hotel M). One of them coughed. Together for a chance moment, the group quickly scattered to sightseeing buses, business lunches and airport terminals. Within hours, some had flown half the world away. Within days, three of the seven were dead, including the man who coughed. That, according to epidemiologists, is how severe acute respiratory syndrome (SARS) spread from Hong Kong to the world (first to Vietnam, Singapore, Canada, Germany)” Emerging diseases Nipah Severe acute respiratory syndrome (SARS) Influenza H5N1 Influenza H1N1 Ebola Reston virus in pigs Severe fever with thrombocytopenia syndrome (SFTS) Re-emerging diseases Chikungunya fever Dengue fever Enteroviruses Rabies Japanese encephalitis HIV/AIDS Streptococcus suis Leptospirosis Drug-resistant diseases MDR tuberculosis XDR tuberculosis MRD P. falciparum malaria Outline • Review of drivers for emergence • One Health approach to disease prevention and control • Future challenges/opportunities SARS virus (coronavirus) Drivers for emergence: • Economic growth • Desire for game meat • Live animal trading Hendra virus (Paramyxovirus) Drivers for emergence: • Population growth/urbanization • Climate change Range expansion of P. alecto 1920s A.Breed CSIRO. CSIRO. Range expansion of P. alecto 1960s A.Breed CSIRO. CSIRO. Range expansion of P. alecto 2007 A.Breed CSIRO. CSIRO. Nipah virus (Bangladesh) Drivers for emergence: • Date palm juice • Cultural tradition Nipah virus (Malaysia) Drivers for emergence: • Unusual farming practice • Forest fire Melaka virus (Reovirus) Drivers for emergence: • Urbanization • Tourism Ebola virus (Filovirus) Driver for emergence: • Bush meat trading Ebola Reston virus (Filovirus) Driver for emergence: • Monkey farming • Intensive pig farming(?) Summary • Bats are important source of emerging zoonotic viruses • Although they all use bats as reservoir, they represent a diverse group of viruses • Different drivers are involved for emergence (even closely related viruses) • It’s impossible to have a one-for-all approach to combat EID pathogens • This trend of emergence is unlikely to stop in the foreseeable future The new SARS-like (SARI) virus • • • • 17 confirmed human cases (11 fatal, 65%) Confirmed human-to-human transmission Likely to be of bat origin Use a different cellular receptor from SARS-CoV Alphacoronaviruses BtCoV/A912/2005 AFCD126/08/05 Mm AFCD68/08/05 Mm AFCD112/08/05 Mm AFCD103/08/05 Mm AFCD101/08/05 Mm AFCD82/08/05 Mm BtCoV/A911/2005 Miniopterus schreibersi BtCoV/A905/2005 BtCoV/A910/2005 BtCoV/A909/2005 BtCoV/A754/2005 AFCD118/08/05 Mm AFCD122/08/05 Mm AFCD140/08/05 Mm AFCD220/12/05 Mm AFCD219/12/05 Mm BtCoV/A1203/2005 BtCoV/A1201/2005 BtCoV/A893/2005 BtCoV/A894/2005 BtCoV/A914/2005 BtCoV/A895/2005 AFCD183/12/05 Mm AFCD264/03/06 Mm BtCoV/A629/2005 WCF86/05/04 Ms WCF96/05/04 Mm AFCD224/12/05 Mm AFCD27/06/05 Mm AFCD62/08/05 Mm AFCD61/08/05 Mm AFCD20/06/05 Mm AFCD26/06/05 Mm AFCD100/08/05 Mm WCF20/05/04 Mp AFCD333/03/06 Mp WCF10/05/04 Mp WCF12/05/04 Mp WCF6/05/04 Mp AFCD337/03/06 Mp AFCD307/03/06 Mp WCF17/05/04 Mp AFCD274/03/06 Mp AFCD169/12/05 Mp AFCD187/12/05 Mp Bat CoV 61 Mp WCF8/05/04 Mp GT190240 btCoV BR98-55/BGR/2008 BtCoV/A1074/2005 BtCoV/A773/2005 Miniopterus schreibersi BtCoV/A1116/2005 WCF88/05/04 Mm HKU7 GT190244 btCoV BR98-31/BGR/2008 GT190243 btCoV BR98-30/BGR/2008 BtCoV R.meg/Australia/CoV100/2007 BtCoV M.aus/Australia/CoV132/2007 BtCoV M.aus/Australia/CoV088/2007 BtCoV M.sch/Australia/CoV146/2007 BtCoV M.aus/Australia/CoV180/1996 AFCD323/03/06 Mp AFCD325/03/06 Mp AFCD309/03/06 Mp WCF4/05/04 Mp WCF14/05/04 Mp AFCD77/08/05 Mm HKU8 BtCoV/A1196/2005 GT190247 btCoV BR98-52/BGR/2008 GT190246 btCoV BR98-40/BGR/2008 GT190242 btCoV BR98-18/BGR/2008 GT190241 btCoV BR98-14/BGR/2008 GT190248 btCoV BR98-53/BGR/2008 GT190245 btCoV BR98-37/BGR/2008 BtCoV 229E Hipposideros/GhanaKwam/19/2008 (Human) BtCoV_Hipposideros/GhanaBoo/344/2008 BtCoV Hipposideros/GhanaKwam/10/2008 BtCoV Hipposideros/GhanaKwam/8/2008 BtCoV/A535/2005 BtCoV/A504/2005 BtCoV/A515/2005 BtCoV/512/2005 Scotophilus kuhlii BtCoV/A527/2005 HKU6-1 Ricketts big-footed bat BtCoV/A613/2005 BtCoV/A619/2005 BtCoV/A620/2005 BtCoV/A900/2005 BtCoV/A897/2005 BtCoV/A898/2005 BtCoV/A604/2005 BtCoV/A701/2005 Myotis ricketti BtCoV/A821/2005 Myotis ricketti BtCoV/A633/2005 BtCoV/A819/2005 BtCoV/A632/2005 BtCoV/A634/2005 M.dau/Germany/D7.3/2007 M.dau/Germany/D8.45/2007 GT190216 btCoV NM98-62/GER/2008 M.dau/Germany/D8.46/2007 M.dau/Germany/D8.38/2007 M.dau/Germany/D8.32/2007 M.dau/Germany/D8.42/2007 P.pyg/Germany/D5.71/2007 P.pyg/Germany/D5.85/2007 P.pyg/Germany/D5.70/2007 P.nat/Germany/D5.16/2007 P.nat/Germany/D5.73/2007 M.das/Germany/D3.5/2007 M.das/Germany/D2.2/2007 M.das/Germany/D3.15/2007 M.das/Germany/D3.3/2007 M.bec/Germany/D6.6/2007 M.das/Germany/D3.10/2007 M.das/Germany/D5.17/2007 M.das/Germany/D3.4/2007 M.das/Germany/D3.28/2007 M.das/Germany/D3.33/2007 M.das/Germany/D3.6/2007 M.das/Germany/D3.38/2007 GT190236 btCoV BR98-12/BGR/2008 GT190232 btCoV BB98-15/BGR/2008 GT190234 btCoV BM48-39/BGR/2008 GT190235 btCoV BM98-05/BGR/2008 GT190233 btCoV BM48-28/BGR/2008 NL63 (Human) RockMountain3 occult myotis BtCoV/A970/2005 Rhinolophus ferrumequinum BtCoV/A977/2005 BtCoV/860/2005 RockMountain48 occult myotis RockMountain11 occult myotis RockMountain27 occult myotis PEDV (Swine) BtCoV M.mac/Australia/CoV034/2008 GT190239 btCoV BNM98-30/BGR/2008 HKU2-1 chinese horseshoe bat HKU2-2 chinese horseshoe bat GT190238 btCoV BB98-41/BGR/2008 GT190237 btCoV 1B BR98-19/BGR/2008 BtCoV S.Amer Trinidad/1FY2BA/2007 BtCoV S.Amer Trinidad/1CO7BA/2007 RockMountain65 big brown bat FIPV ((Feline) TGEV (Swine) 0.05 Betacoronaviruses BtCoV/367A/2005 BtCoV/908/2005 BtCoV/A906/2005 BtCoV/310A/2005 BtCoV/355A/2005 Pipistrellus pipistrellus BtCoV/364A/2005 BtCoV/309/2005 BtCoV/363A/2005 BtCoV/303/2005 BtCoV/301/2005 BtCoV/311A/2005 BtCoV/A957/2005 BtCoV/A434/2005 Pipistrellus pipistrellus BtCoV/365A/2005 HKU5-1 Japanese pipistrelle BtCoV/A1206/2005 HKU5-5 Japanese pipistrelle HKU5-2 Japanese pipistrelle HKU5-3 Japanese pipistrelle BtCoV/A421/2005 BtCoV/A437/2005 BtCoV/A433/2005 BtCoV/427/2005 BtCoV/A429/2005 BtCoV/242/2005 BtCoV/133/2005 Tylonycleris pachypus HKU4-4 lesser bamboo bat HKU4-1 lesser bamboo bat HKU4-3 lesser bamboo bat BCoV (Bovine) OC43 (Human) MHV (Mouse) HKU1 (Human) BtCoV_Hipposideros/GhanaKwam/24/2008 BtCoV_Hipposideros/GhanaKwam/27/2008 BtCoV_Hipposideros/GhanaKwam/31/2008 BtCoV Hipposideros/GhanaBoo/348/2008 BtCoV Hipposideros/GhanaKwam/20/2008 BtCoV Hipposideros/GhanaKwam/22/2008 BtCoV R.aur/Australia/CoV000/2006 BtCoV/A1018/2005 Rhiniolophus sinicus HKU3 BtCoV/273/2005 Rhinolophus ferrumequinum BtCoV/279/2005 Rhinolophus macrotis SARS-CoV (Human) GT190229_btCoV_BM48-34/BGR/2008 GT190215 btCoV BM48-31/BGR/2008 GT190228 btCoV BM48-32/BGR/2008 GT190220 btCoV BM48-48/BGR/2008 GT190219 btCoV BM98-65/BGR/2008 GT190218 btCoV BB98-18/BGR/2008 GT190217 btCoV BB98-16/BGR/2008 GT190231 btCoV BNM98-29/BGR/2008 GT190226 btCoV BB98-43/BGR/2008 GT190224 btCoV BM48-12/BGR/2008 GT190230 btCoV BM48-35/BGR/2008 GT190221 btCoV 2B BR98-19/BGR/2008 GT190222 btCoV BM98-01/BGR/2008 GT190223 btCoV BM98-13/BGR/2008 GT190227 btCoV BM98-07/BGR/2008 GT190225 btCoV BM98-05/BGR/2008 0.05 L. Poon, HKU Nature 2013, 495: 176 Recombinant subunit vaccine against Hendra virus - an One Health approach Transmission Risk factors: Housed outside Paddock with fruit trees During flying fox birthing season Hendra virus transmission between species What is the best (realistic) countermeasure strategy (ies)? X Hendra/Australia • Vaccine for horses Nipah/Malaysia • Post-exposure therapeutics for humans • Rapid diagnosis (ideally point-of-care test platform) Nipah/Bangladesh The HeV attachment protein (G) – Main target for neutralising antibody – Recombinant soluble G (sG) maintains conformation and biological function Establishing the horse infection model: Redlands 2008 Post mortem in a BSL4 lab! HeV vaccine studies in horses - summary • Immunised horses exposed to an otherwise lethal dose of HeV – Remained clinically healthy – Did not develop histological lesions in target tissues • No virus re-isolated • No viral genome detected – No virus re-isolated from clinical samples • Genome recovered from nasal swab of one animal – Self-limiting local infection – Did not show a boost in antibody titre after virus exposure Formal release: Nov 1, 2012 Equivac® HeV Major features • Effective against both Hendra and Nipah • A truly One Health vaccine • Compatible with different adjuvant formulations • First licenced vaccine against any BSL4 agent Challenges/Opportunities • Active surveillance • Targeting the “known unknowns” first • Capacity building during “peace time’ (get ready for the “unknown unknowns” • Multi-disciplinary approach (One Health) • Stronger regional collaboration Asian Communicable Disease Centre (ACDC)